Literature DB >> 1693221

Infection of monocytes/macrophages by HIV in vitro.

H von Briesen1, R Andreesen, R Esser, W Brugger, C Meichsner, K Becker, H Rübsamen-Waigmann.   

Abstract

Because of the very important role of the mononuclear phagocyte system in the immunopathogenesis of HIV infection, a culture system for in vitro studies of infection of monocytes/macrophages with HIV was developed. A method is described for the infection of human monocytes/macrophages cultured on hydrophobic membranes (Teflon) with different strains of HIV. The HIV isolates can be characterized according to their replication potential on monocytes/macrophages cultures. The biological properties of some HIV1 and HIV2 isolates are compared in lymphocyte and monocyte/macrophage cultures.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1693221     DOI： 10.1016/0923-2516(90)90025-e

Source DB:  PubMed          Journal:  Res Virol        ISSN： 0923-2516


  10 in total

1.  Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes.

Authors:  H Ruppach; P Nara; I Raudonat; Z Elanjikal; H Rübsamen-Waigmann; U Dietrich
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro.

Authors:  A R Bender; H von Briesen; J Kreuter; I B Duncan; H Rübsamen-Waigmann
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

3.  In vitro and in vivo activities of AIC292, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.

Authors:  Steffen Wildum; Daniela Paulsen; Kai Thede; Helga Ruebsamen-Schaeff; Holger Zimmermann
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

4.  Short chain fatty acids potently induce latent HIV-1 in T-cells by activating P-TEFb and multiple histone modifications.

Authors:  Biswajit Das; Curtis Dobrowolski; Abdel-Malek Shahir; Zhimin Feng; Xiaolan Yu; Jinfeng Sha; Nabil F Bissada; Aaron Weinberg; Jonathan Karn; Fengchun Ye
Journal:  Virology       Date:  2014-11-14       Impact factor: 3.616

5.  The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.

Authors:  E P Rieber; C Federle; C Reiter; S Krauss; L Gürtler; J Eberle; F Deinhardt; G Riethmüller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

6.  Human blood-derived macrophages enhance barrier function of cultured primary bovine and human brain capillary endothelial cells.

Authors:  Dietmar Zenker; David Begley; Hansjürgen Bratzke; Helga Rübsamen-Waigmann; Hagen von Briesen
Journal:  J Physiol       Date:  2003-06-26       Impact factor: 5.182

7.  Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages: a possibility for antiviral drug targeting.

Authors:  V Schäfer; H von Briesen; R Andreesen; A M Steffan; C Royer; S Tröster; J Kreuter; H Rübsamen-Waigmann
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

8.  Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats.

Authors:  Prashant Kumar; Yeruva Samrajya Lakshmi; Bhaskar C; Kishore Golla; Anand K Kondapi
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

9.  Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue.

Authors:  Michael Schindler; Devi Rajan; Carina Banning; Peter Wimmer; Herwig Koppensteiner; Alicja Iwanski; Anke Specht; Daniel Sauter; Thomas Dobner; Frank Kirchhoff
Journal:  Retrovirology       Date:  2010-01-15       Impact factor: 4.602

10.  Combination antiretroviral drugs in PLGA nanoparticle for HIV-1.

Authors:  Christopher J Destache; Todd Belgum; Keith Christensen; Annemarie Shibata; Akhilesh Sharma; Alekha Dash
Journal:  BMC Infect Dis       Date:  2009-12-09       Impact factor: 3.090
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.